ALT5 Sigma (ALTS) Competitors $2.19 -0.22 (-9.13%) Closing price 04:00 PM EasternExtended Trading$2.16 -0.02 (-1.14%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALTS vs. EVO, SNDX, AVDL, ORIC, JANX, LENZ, XERS, SION, NUVB, and ATAIShould you be buying ALT5 Sigma stock or one of its competitors? The main competitors of ALT5 Sigma include Evotec (EVO), Syndax Pharmaceuticals (SNDX), Avadel Pharmaceuticals (AVDL), Oric Pharmaceuticals (ORIC), Janux Therapeutics (JANX), LENZ Therapeutics (LENZ), Xeris Biopharma (XERS), Sionna Therapeutics (SION), Nuvation Bio (NUVB), and atai Life Sciences (ATAI). These companies are all part of the "pharmaceutical products" industry. ALT5 Sigma vs. Its Competitors Evotec Syndax Pharmaceuticals Avadel Pharmaceuticals Oric Pharmaceuticals Janux Therapeutics LENZ Therapeutics Xeris Biopharma Sionna Therapeutics Nuvation Bio atai Life Sciences Evotec (NASDAQ:EVO) and ALT5 Sigma (NASDAQ:ALTS) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Does the media prefer EVO or ALTS? In the previous week, ALT5 Sigma had 4 more articles in the media than Evotec. MarketBeat recorded 5 mentions for ALT5 Sigma and 1 mentions for Evotec. ALT5 Sigma's average media sentiment score of 1.54 beat Evotec's score of 0.27 indicating that ALT5 Sigma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evotec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ALT5 Sigma 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals and insiders have more ownership in EVO or ALTS? 5.8% of Evotec shares are owned by institutional investors. Comparatively, 6.3% of ALT5 Sigma shares are owned by institutional investors. 1.0% of Evotec shares are owned by insiders. Comparatively, 0.7% of ALT5 Sigma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, EVO or ALTS? Evotec has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500. Comparatively, ALT5 Sigma has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Do analysts rate EVO or ALTS? Evotec currently has a consensus price target of $7.00, indicating a potential upside of 75.00%. Given Evotec's stronger consensus rating and higher probable upside, analysts plainly believe Evotec is more favorable than ALT5 Sigma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evotec 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25ALT5 Sigma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has preferable earnings and valuation, EVO or ALTS? ALT5 Sigma has lower revenue, but higher earnings than Evotec. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvotec$862.40M1.65-$212.18MN/AN/AALT5 Sigma$12.53M21.84-$6.24MN/AN/A Is EVO or ALTS more profitable? Evotec has a net margin of -20.14% compared to ALT5 Sigma's net margin of -74.89%. Evotec's return on equity of -16.94% beat ALT5 Sigma's return on equity.Company Net Margins Return on Equity Return on Assets Evotec-20.14% -16.94% -8.14% ALT5 Sigma -74.89%-179.27%-16.28% SummaryEvotec beats ALT5 Sigma on 9 of the 14 factors compared between the two stocks. Get ALT5 Sigma News Delivered to You Automatically Sign up to receive the latest news and ratings for ALTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALTS vs. The Competition Export to ExcelMetricALT5 SigmaFIN IndustryFinance SectorNASDAQ ExchangeMarket Cap$301.12M$8.02B$12.65B$10.55BDividend YieldN/A4.88%5.55%4.78%P/E RatioN/A16.0832.6827.19Price / Sales21.846.3029.90132.96Price / CashN/A31.5022.7962.13Price / Book4.472.682.236.65Net Income-$6.24M$310.95M$1.02B$276.79M7 Day Performance-24.22%-3.28%-1.25%-1.51%1 Month Performance-40.65%0.16%-1.64%5.45%1 Year Performance-3.10%17.61%534.05%36.24% ALT5 Sigma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALTSALT5 Sigma0.6567 of 5 stars$2.19-9.1%N/A+12.6%$301.12M$12.53M0.00170Positive NewsEVOEvotec1.703 of 5 stars$3.92-1.8%$7.00+78.6%+35.5%$1.42B$862.40M0.004,827SNDXSyndax Pharmaceuticals3.8056 of 5 stars$16.45+0.3%$39.22+138.4%-23.8%$1.41B$23.68M-4.23110News CoverageAnalyst ForecastGap UpAVDLAvadel Pharmaceuticals2.5865 of 5 stars$14.47-0.4%$20.86+44.1%+14.8%$1.41B$169.12M-482.3370ORICOric Pharmaceuticals4.3292 of 5 stars$14.12-2.0%$17.29+22.4%+46.0%$1.40BN/A-7.4780Gap UpJANXJanux Therapeutics2.178 of 5 stars$22.69-0.3%$78.31+245.1%-46.4%$1.37B$10.59M-12.6130LENZLENZ Therapeutics1.951 of 5 stars$46.94+1.8%$49.60+5.7%+59.6%$1.32BN/A-24.71110High Trading VolumeXERSXeris Biopharma2.8681 of 5 stars$8.28+1.8%$7.08-14.5%+207.0%$1.31B$203.07M-39.43290News CoverageAnalyst UpgradeSIONSionna Therapeutics2.0173 of 5 stars$28.61-2.2%$38.00+32.8%N/A$1.29BN/A0.0035News CoverageInsider TradeNUVBNuvation Bio2.5704 of 5 stars$3.67-2.8%$7.86+114.4%+62.0%$1.29B$7.87M-5.8260Analyst ForecastATAIatai Life Sciences3.5593 of 5 stars$5.54+1.3%$11.25+103.1%+446.8%$1.28B$310K-8.0380News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies EVO Alternatives SNDX Alternatives AVDL Alternatives ORIC Alternatives JANX Alternatives LENZ Alternatives XERS Alternatives SION Alternatives NUVB Alternatives ATAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALTS) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhite House Letter Reveals “MAGA’s Master Plan”If you thought tariffs were big news, the next phase of MAGA’s economic plan could be far more transformative ...StocksToTrade | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThis dark force is about to change everythingTwo Nobel Prize winners warn of this once-in-a-generation wealth shift…THE FINAL DISPLACEMENT An unstoppabl...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALT5 Sigma Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share ALT5 Sigma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
